Glyburide Tablets Articles
Revolution In Diabetes Type II Treatment Forecast
23 October 1995
MMD Essential To Hoechst For Leading Pharma Role
3 April 1995
Hoechst Refocuses Following Restructuring
12 December 1994
Hoechst Recovers From 1993 Malaise
5 December 1994
LILLY TO MARKET GENERIC TAGAMET
25 April 1994
HOECHST CELANESE ACQUIRES US GENERICS CO
25 October 1993
WORLD ENDOCRINE MARKET AND FORECASTS
29 March 1993
Hoechst Roussel has no plans to market Glubate
22 June 1992
Showing 1-8 of 8 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
